$GHDX Headlines 4 stocks with charts pointing higher

New Post Public Reply Private Reply Replies (0) Message Board

Apr 12, 2014 at 10:22 AM

$GHDX Headlines

4 stocks with charts pointing higher 6:58 a.m. Oct. 2, 2012 - The Trading Deck
Genomic Health up 15% on business update, earnings 10:52 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Stocks to watch Tuesday: Kenexa, Coinstar, ViaSat 7:51 a.m. Feb. 7, 2012 - MarketWatch
Biotech analysts lukewarm on diagnostic stocks 4:16 p.m. Sept. 29, 2011 - Val Brickates Kennedy
Updates, advisories and surprises 7:01 p.m. Nov. 9, 2010 - MarketWatch
Genomic Health soars as drug indexes ease 12:14 p.m. Nov. 9, 2010 - Val Brickates Kennedy
Genomic Health rockets as drug indexes ease 11:14 a.m. Nov. 9, 2010 - Val Brickates Kennedy
Setting up to retest the 2008 lows 9:27 a.m. Sept. 11, 2008 - Michael Ashbaugh
Genomic Health up 4.4% at $17.48 9:40 a.m. March 27, 2007 - Tomi Kilgore
Genomic Health upped to outperform at Piper Jaffray 7:36 a.m. March 27, 2007 - Tomi Kilgore
Updates, advisories and surprises 11:01 p.m. Feb. 7, 2007 - MarketWatch
Wednesday's biggest stock gainers and decliners 7:26 p.m. Feb. 7, 2007 - Michael Baron
Genomic Health shares fall as loss widens in fourth quarter 11:32 a.m. Feb. 7, 2007 - Gabriel Madway
Genomic Health shares fall on Q4 results 11:27 a.m. Feb. 7, 2007 - Gabriel Madway
Genomic Health shares dwon 7.9% at $19.79 11:27 a.m. Feb. 7, 2007 - Gabriel Madway
Wednesday's biggest stock gainers and decliners 7:00 p.m. Jan. 17, 2007 - Michael Baron
Drug stocks rise, but Isis slides on note offering 5:35 p.m. Jan. 17, 2007 - Val Brickates Kennedy
Genomic Health down 9.9% at $21.33 10:48 a.m. Jan. 17, 2007 - Tomi Kilgore
Genomic Health cut to equal weight at Lehman Bros. 10:26 a.m. Jan. 17, 2007 - Tomi Kilgore
Wednesday's biggest stock gainers and decliners 5:56 p.m. Jan. 10, 2007 - Michael Baron

Balanced View on Genomic Health - Analyst Blog 3:20 p.m. April 8, 2014 - Zacks.com
Genomic Health, Inc. (GHDX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. April 4, 2014 - Zacks.com
Bear of the Day: Genomic Health (GHDX) - Bear of the Day 4:09 a.m. April 3, 2014 - Zacks.com
Genomic Health Unveils Oncotype DX Data - Analyst Blog 6:15 p.m. March 20, 2014 - Zacks.com
Foundation Medicine Lockup Expiration Could Flood The Market, Depressing Share Price 12:57 p.m. March 13, 2014 - Seeking Alpha
Fountain Medicine Lockup Expiration Could Flood The Market, Depressing Share Price 12:57 p.m. March 13, 2014 - Seeking Alpha
10-K: GENOMIC HEALTH INC 4:44 p.m. March 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Zacks Rank #5 Additions for Thursday - Tale of the Tape 10:30 a.m. Feb. 27, 2014 - Zacks.com
5 Biotechnology Stocks to Sell Now 3:15 a.m. Feb. 19, 2014 - InvestorPlace.com
What Makes Genomic Health (GHDX) a Strong Sell? - Tale of the Tape 9:45 a.m. Feb. 13, 2014 - Zacks.com
Weakness seen in Genomic Health (GHDX): Stock Tumbles 9.0% - Tale of the Tape 9:43 a.m. Feb. 6, 2014 - Zacks.com
Q4 Loss Narrower Than Expected at Genomic, Revs Up Y/Y - Analyst Blog 11:30 a.m. Feb. 5, 2014 - Zacks.com
UPDATE: Bank of America Reiterates on Genomic Health as 2014 Outlook is Below Expectations 10:15 a.m. Feb. 5, 2014 - benzinga.com
Genomic Health Management Discusses Q4 2013 Results - Earnings Call Transcript 9:10 p.m. Feb. 4, 2014 - Seeking Alpha
Q4 2013 Genomic Health Inc Earnings Conference call (Webcast) 5:25 p.m. Feb. 4, 2014 - Seeking Alpha
A New Approach to Prostate Cancer 8:12 p.m. Jan. 13, 2014 - The Wall Street Journal Interactive Edition
MannKind Corp. (MNKD) Surges: Stock Moves 18.4% Higher - Tale of the Tape 10:21 a.m. Jan. 10, 2014 - Zacks.com
InterMune (ITMN) Jumps: Stock Rises 9.5% - Tale of the Tape 9:57 a.m. Jan. 10, 2014 - Zacks.com
Agenus (AGEN) Jumps: Stock Adds 8.8% in Session - Tale of the Tape 9:51 a.m. Jan. 10, 2014 - Zacks.com
Cytori Therapeutics (CYTX) Soars: Stock Adds 11.4% in Session - Tale of the Tape 10:21 a.m. Jan. 9, 2014 - Zacks.com

Genomic Health Announces Presentation of New Data Further Supporting Use of Oncotype DX® in Europe 8:00 a.m. March 19, 2014 - PR Newswire - PRF
Genomic Health Announces Year-End 2013 Financial Results, Provides 2014 Financial Outlook 5:01 p.m. Feb. 4, 2014 - PR Newswire - PRF
Genomic Health Announces Results of Oncotype DX® Colon Cancer Studies Presented at 2014 American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) Symposium 9:00 a.m. Jan. 29, 2014 - PR Newswire - PRF
Genomic Health to Announce Fourth Quarter and Year-End 2013 Financial Results and Host Conference Call on Tuesday, February 4, 2014 9:00 a.m. Jan. 28, 2014 - PR Newswire - PRF
Specialised Therapeutics Australia Partners with Genomic Health Inc. to Deliver Novel Genomic Test to Breast Cancer Patients 9:00 a.m. Jan. 7, 2014 - PR Newswire
Genomic Health Announces Presentation at J.P. Morgan Healthcare Conference 5:00 p.m. Jan. 6, 2014 - PR Newswire
Healthcare Companies Announce Study Results, Acquisitions and Company Updates - Research Report on Sirona Dental Systems, Ligand Pharmaceuticals, Genomic Health, Unilife, and Sykes 9:00 a.m. Dec. 24, 2013 - PR Newswire
Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health 9:00 a.m. Dec. 16, 2013 - PR Newswire
Genomic Health Announces Presentation of New Oncotype DX® Studies Underscoring Unique Value of the Test in Early-Stage Breast Cancer at the 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium 9:35 a.m. Dec. 14, 2013 - PR Newswire
Invitae Offers BRCA1/BRCA2 Testing, Providing Clinicians With a Reliable, Fast, Affordable Option for Patients 9:30 a.m. Dec. 11, 2013 - BusinessWire
Invitae Completes $40 Million Series E Financing 10:00 a.m. Dec. 10, 2013 - BusinessWire
Genomic Health Announces Presentation of Oncotype DX® Studies at the 2013 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) 9:00 a.m. Dec. 4, 2013 - PR Newswire
Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer 5:01 p.m. Nov. 25, 2013 - PR Newswire
Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer 5:01 p.m. Nov. 25, 2013 - BusinessWire
Genomic Health Announces Publication of Oncotype DX® Prostate Cancer Test Analytical Validation Study 9:00 a.m. Nov. 22, 2013 - PR Newswire
Applied Proteomics Appoints Premal S. Shah As Vice President Of Business Development 9:00 a.m. Nov. 19, 2013 - PR Newswire
Company Statements, Study Results, Stock Movements, Awards and Stock Splits - Research Report on WebMD, Cerner, Waters, Medidata and Genomic Health 9:00 a.m. Nov. 18, 2013 - PR Newswire
Genomic Health Announces Colon Cancer Publication in Journal of Clinical Oncology Supporting Wider Oncotype DX® Utilization 9:00 a.m. Nov. 13, 2013 - PR Newswire
Companies in the Healthcare Sector Report Financial Results, and Scheduled Conference calls - Research Report on OXiGENE, BioTelemetry, Abiomed, Emeritus, and Genomic Health 9:00 a.m. Nov. 11, 2013 - PR Newswire
Genomic Health Announces Third Quarter 2013 Financial Results and Business Progress 5:01 p.m. Nov. 5, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Retirement Dreams Dashed: 61% Withdraw Early

By Olivia Taylor Updated Nov 14, 2026 Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Luvme Hair Offers Wig Variety for Winter Fashion

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...